UND Home > SOMHS Home > Department of Pharmacology, Physiology, & Therapeutics
Pharmacology, Physiology, & Therapeutics
BIMD HomeAbout BIMDBIMD FacultyBIMD DepartmentsBIMD CoursesBIMD Seminars
Microbiology and Immunology Links
Misc. Links
'

Thad A. Rosenberger, Ph.D.
Assistant Professor

University Email Address: trosenberger@medicine.nodak.edu
Office Phone: 701-777-0591
Lab Phone: 701-777-0590
Office Fax: 701-777-4490

GRADUATE STUDENT POSITIONS ARE NOW CURRENTLY AVAILABLE

Keywords:

Alzheimers disease, multiple sclerosis, cerebral ischemia, spinal cord injury, AIDS-related dementia, neurodegeneration, neuroinflammation, brain, lipid metabolism, lipid-mediated signal transduction, fatty acid metabolism, phospholipid metabolism, arachidonic acid, eicosanoids, ether phospholipid, plasmalogens, phospholipases A2, phospholipases C, analytical lipid techniques

Education/Training:

  • Postdoctoral Fellow, National Institutes on Aging, National Institutes of Health, Bethesda, Maryland
  • Ph.D., Medical Biochemistry, The Ohio State University, Columbus, Ohio

Research Interest:

Inflammation induced tissue injury is a major and primary contributing factor to the pathogenesis of a variety of human brain diseases including; cerebral ischemia, spinal cord injury, multiple sclerosis, AIDS-related dementia, and Alzheimers disease. Inflammation induces the production, by activated microglia and astrocytes, of the pro-inflammatory cytokines (e.g. IL-1, TNFa, etc.). These cytokines bind to receptors that, among other things, couple to “effector” enzymes such as phospholipases A2 and phospholipases C, provoking pathological lipid-mediated signaling cascades. Induction of these cascades is known to disrupt membrane phospholipid metabolism, increase the expression of enzymes found in the inflammatory cascades, and ultimately result in altered cellular homeostasis and cell death. Unfortunately, little is known concerning the relative contribution that specific inflammation-induced signaling pathways play in the progression of neurodegenerative events associated with these diseases.

Our long-term goal is to understand the extent by which alterations in lipid-mediated signal transduction contribute to the progression of injury associated with neuroinflammation and to use this knowledge to develop therapeutic strategies to treat these diseases. Studies in our laboratory include: identifying lipid-mediated signaling pathways that contribute to the progression of inflammatory events in the central nervous system, identifying the specific roles phospholipases A2 and C play in the progression of disease, and to distinguish the role that ether phospholipid metabolism has in normal and injured brain.

Refereed Publications:

Non-refereed Publications:

  • Deutsch, J., and Rosenberger, T.A. (2005) HPLC analysis of acyl-coenzyme A esters from mammalian tissue, in HPLC of Acyl Lipids (Lin, J. and McKeon, T.A. editors) HNB Publishing, New York 499-520.
  • Farooqui, A.A., Rosenberger, T.A., and Horrocks, L.A. (1997) Arachidonic acid, neurotrauma and neurodegenerative diseases, in Fatty Acids: Biochemistry and Behavior, (Mostofsky, D.I. and Yehuda, S. editors) Humana Press, Totowa, 277-295.
Department of Pharmacology, Physiology & Therapeutics
University of North Dakota School of Medicine & Health Sciences
501 N. Columbia Road, Stop 9037
Grand Forks, ND 58202-9037
Phone: (701) 777-4293
Fax: 701-777-4490
©2008 University of North Dakota
UND Home Page